Figure 3 Female observed survival of the entire cohort versus expected survival based on aggregate mortality statistics of all participating countries. Female expected versus observed survival rates were 99.7% versus 98.9%, 97.8% versus 96.1%, and 94.6% versus 90.6%, one, five, and 10 years after diagnosis, respectively. No, number of patients.